The latest immunotherapy news and developments
Just like people, some T cells have excellent memories. These subtypes known as memory T…
Among patients with newly diagnosed advanced non-small cell lung cancer (NSCLC) with high tumour mutational…
A new type of cancer vaccine has yielded promising results in an initial clinical trial…
Further evidence that immunotherapy provides long-term survival benefit for patients with lung cancer was presented…
World leading Victorian medical researchers have pioneered a revolutionary new drug that will change how…
Nicholas Huntington, Walter and Eliza Hall Institute Keytruda (generic name pembrolizumab) is an immunotherapy drug…
The pre-clinical study, published in Clinical Cancer Research, by Dr Sarah Buchan and colleagues, combined antibodies…
Breast cancer, in the stage with distant metastases, is an incurable disease with a 5…
The Journal of Clinical Investigation has published a scientific article describing ONC201’s ability to cause intratumoural accumulation…
A Ludwig Cancer Research study shows that ovarian cancer, which has proved resistant to currently…